Drugs / supplemental oxygen therapy
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07651917 Comparator | Jun → Jul 2026 overdue | cognitive disorder | University of Zurich | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | supplemental oxygen therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07651917 ↗ |
| Route | Intranasal | “administered through nasal canula.” NCT07651917 ↗ |